down arrow

Ortoma AB

  • Market Cap: Micro Cap
  • Industry: Hospital
  • ISIN: SE0005676103
SEK
14.80
0.05 (0.34%)

Dec 04

OME

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

7.0633.60
Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

Negative results in Jun 25

  • PRE-TAX PROFIT(Q) At SEK 1.29 MM has Fallen at -76.25%
  • NET PROFIT(Q) At SEK 1.29 MM has Fallen at -76.25%
  • RAW MATERIAL COST(Y) Grown by 54.85% (YoY)
2

Risky -

stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Hospital

stock-summary
Market cap

SEK 531 Million (Micro Cap)

stock-summary
P/E

83.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.23

stock-summary
Return on Equity

-4.54%

stock-summary
Price to Book

3.22

Revenue and Profits:
Net Sales:
19 Million
(Quarterly Results - Jun 2025)
Net Profit:
1 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-36.21%
0%
-36.21%
6 Months
10.45%
0%
10.45%
1 Year
48.3%
0%
48.3%
2 Years
17.93%
0%
17.93%
3 Years
0%
0%
0.0%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%

Ortoma AB for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Icon
No Recent News for the Company
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
139.13%
EBIT Growth (5y)
5.79%
EBIT to Interest (avg)
-5.64
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.17
Sales to Capital Employed (avg)
0.29
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
1.35%
ROE (avg)
1.30%
Valuation key factors
Factor
Value
P/E Ratio
83
Industry P/E
Price to Book Value
2.85
EV to EBIT
63.36
EV to EBITDA
23.26
EV to Capital Employed
3.56
EV to Sales
5.46
PEG Ratio
0.69
Dividend Yield
NA
ROCE (Latest)
5.62%
ROE (Latest)
3.42%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
Bearish
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bullish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is 7.43% vs 3.55% in Jun 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is -75.93% vs -58.78% in Jun 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Jun'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "18.80",
          "val2": "17.50",
          "chgp": "7.43%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "5.90",
          "val2": "8.40",
          "chgp": "-29.76%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "1.30",
          "val2": "5.40",
          "chgp": "-75.93%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "144.40%",
          "val2": "307.70%",
          "chgp": "-16.33%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 28.87% vs 0.00% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 47.03% vs -38.61% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "49.10",
          "val2": "38.10",
          "chgp": "28.87%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-1.50",
          "val2": "1.80",
          "chgp": "-183.33%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.60",
          "chgp": "-100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-11.60",
          "val2": "-21.90",
          "chgp": "47.03%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-279.00%",
          "val2": "44.20%",
          "chgp": "-32.32%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Jun'25 - YoYstock-summary
Jun'25
Jun'24
Change(%)
Net Sales
18.80
17.50
7.43%
Operating Profit (PBDIT) excl Other Income
5.90
8.40
-29.76%
Interest
0.00
0.00
Exceptional Items
-0.00
0.00
Consolidate Net Profit
1.30
5.40
-75.93%
Operating Profit Margin (Excl OI)
144.40%
307.70%
-16.33%
USD in Million.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in quarter ended Jun 2025 is 7.43% vs 3.55% in Jun 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Jun 2025 is -75.93% vs -58.78% in Jun 2024

All Quarterly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
49.10
38.10
28.87%
Operating Profit (PBDIT) excl Other Income
-1.50
1.80
-183.33%
Interest
0.00
0.60
-100.00%
Exceptional Items
0.00
0.00
Consolidate Net Profit
-11.60
-21.90
47.03%
Operating Profit Margin (Excl OI)
-279.00%
44.20%
-32.32%
USD in Million.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is 28.87% vs 0.00% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 47.03% vs -38.61% in Dec 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Ortoma AB stock-summary
stock-summary
Ortoma AB
Hospital
Ortoma AB is a Sweden-based company engaged in the medical technology. It develops an operation system for planning and positioning of joint implants in hip, knee and back surgery. The Company’s portfolio of products include Ortoma Treatment Solution, an integrated planning and measuring system, including a camera, navigation equipment and three-dimensional (3D) graphics for planning and performing prosthetic operations; Ortoma Plan, a preoperative planning system which allows surgeons to measure patient’s anatomy based on computer tomography or magnetic resonance, view it in 3D and plan operation and choice of implant before surgery; and Ortoma Guide, a navigation device which allows precise measurement and positioning of implants during operations. The Company cooperates with orthopedic departments at Sahlgrenska University Hospital, Skane University Hospital and Gothenburg University.
Company Coordinates stock-summary
Company Details
Falkenbergsgatan 3 8Tr , GOETEBORG None : 412 85
stock-summary
Tel: 46 31 7735163
stock-summary
http://www.ortoma.com
stock-summary
Registrar Details
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."